United Kingdom · 
Who invested in Curve Therapeutics?
Curve Therapeutics's investors include U.S. Venture Partners.
202220232024
$2.8MSeries A$51MSeries A
United Kingdom · Series A startup
Who invested in Curve Therapeutics
Funding summaryUpdated 26 Oct 2026
$54Mraised across 2 rounds since 2021, from 2 sources
$2.8MSeries A$51MSeries A
- Latest round
- Series A, $51MFeb 2024
- Step-upi
- 18.2×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $2.8M May 2021
- Biggest round
- $51M Series A · Feb 2024
- Between rounds
- 2.8 years from the last two
The rounds
- Feb 2024
- May 2021Series A$2.8M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Curve Therapeutics filed 2 raises, $36M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jan 2024$33MUK share allotment
- May 2021$2.8MUK share allotment
Founders and team
From Curve Therapeutics's own website: 7 on the team.
- Dr Richard RathmellVice President of Chemistry
- Dr Rob JeprasVice President of Screening
- Dr Sally PriceVice President of Biology
- Dr Rab PrinjhaChief R&D Officer
- Simon JonesChief Financial Officer and Chief Operating Officer
- Dr Cora GriffinHead of Business Development
- Prof. Adrian HarrisBoard of Directors
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Curve Therapeutics
How much has Curve Therapeutics raised?
Curve Therapeutics has raised $54M across 2 rounds since 2021.
When did Curve Therapeutics last raise?
Curve Therapeutics's most recent round was a Series A of $51M in Feb 2024.
What was Curve Therapeutics's biggest round?
Its most recent round, $51M in Feb 2024, is also its largest on record.
Who backed Curve Therapeutics first?
Curve Therapeutics's first round on record, in Feb 2024, was backed by U.S. Venture Partners.
What stage is Curve Therapeutics at?
Curve Therapeutics's latest named round is a Series A, in Feb 2024.
Where is Curve Therapeutics based?
Curve Therapeutics is based in the United Kingdom.
Companies like Curve Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.